<p xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" id="Par5">On TriNetX, 3573 vaccinated and 46,329 unvaccinated patients who were hospitalized for AIS within 30 days of being infected with COVID-19 were identified, with an average age of 71&#8201;&#177;&#8201;12 years vs 65&#8201;&#177;&#8201;15 years, respectively (Table <xref rid="Tab1" ref-type="table">1</xref>). After propensity score matching, 3,569 individuals remained in both the vaccinated and unvaccinated cohorts. Among 3569 patients in the vaccinated cohort, 2453 (68.7%) had received a Pfizer mRNA vaccine, 997 (27.9%) received a Moderna mRNA vaccine, and the remaining 119 (3.3%) received non-mRNA vaccines (either AstraZeneca or Johnson&amp;Johnson).<table-wrap id="Tab1"><label>Table 1</label><caption><p>Characteristics of patients with COVID-19 associated stroke before and after propensity matching</p></caption><table frame="hsides" rules="groups"><thead><tr><th/><th colspan="4">Before matching</th><th colspan="4">After matching</th></tr><tr><th>Variables</th><th>Unvaccinated <italic>N</italic>&#8201;=&#8201;46,329</th><th>Vaccinated <italic>N</italic>&#8201;=&#8201;3,573</th><th><italic>P</italic> Value</th><th>Std Diff</th><th>Unvaccinated <italic>N</italic>&#8201;=&#8201;3,569</th><th>Vaccinated <italic>N</italic>&#8201;=&#8201;3,569</th><th>P-Value</th><th>Std Diff</th></tr></thead><tbody><tr><td colspan="9"><bold>Demographics</bold></td></tr><tr><td>&#8195;Age, overall, years</td><td>65&#8201;&#177;&#8201;15</td><td>71&#8201;&#177;&#8201;12</td><td>&lt; 0.001</td><td>0.43</td><td>72&#8201;&#177;&#8201;12</td><td>71&#8201;&#177;&#8201;12</td><td>&lt;0.001</td><td>0.10</td></tr><tr><td>&#8195;Female</td><td>20,818 (45)</td><td>1733 (49)</td><td>&lt;0.001</td><td>0.07</td><td>1742 (49)</td><td>1729 (48)</td><td>0.76</td><td>0.01</td></tr><tr><td>&#8195;White</td><td>32,142 (69)</td><td>2552 (71)</td><td>0.01</td><td>0.05</td><td>2615 (73)</td><td>2551 (72)</td><td>0.09</td><td>0.04</td></tr><tr><td>&#8195;Black or African American</td><td>8571 (19)</td><td>728 (20)</td><td>0.01</td><td>0.05</td><td>663 (19)</td><td>725 (20)</td><td>0.06</td><td>0.04</td></tr><tr><td>&#8195;Asian</td><td>865 (2)</td><td>85 (2)</td><td>0.03</td><td>0.04</td><td>108 (3)</td><td>85 (2)</td><td>0.09</td><td>0.04</td></tr><tr><td>&#8195;Unknown race</td><td>4530 (10)</td><td>189 (5)</td><td>&lt;0.001</td><td>0.17</td><td>164 (5)</td><td>189 (5)</td><td>0.17</td><td>0.03</td></tr><tr><td colspan="9"><bold>Medical History</bold></td></tr><tr><td>&#8195;Hypertension</td><td>24,745 (53)</td><td>2938 (82)</td><td>&lt; 0.001</td><td>0.65</td><td>2940 (82)</td><td>2934 (82)</td><td>0.85</td><td>0.004</td></tr><tr><td>&#8195;Hyperlipidemia</td><td>16,583 (36)</td><td>2385 (67)</td><td>&lt;0.001</td><td>0.65</td><td>2352 (66)</td><td>2381 (67)</td><td>0.47</td><td>0.02</td></tr><tr><td>&#8195;Diabetes Mellitus</td><td>15,940 (34)</td><td>1757 (49)</td><td>&lt;0.001</td><td>0.30</td><td>1674 (47)</td><td>1754 (49)</td><td>0.06</td><td>0.05</td></tr><tr><td>&#8195;Coronary artery disease</td><td>10,146 (22)</td><td>1590 (45)</td><td>&lt; 0.001</td><td>0.49</td><td>1510 (42)</td><td>1586 (44)</td><td>0.07</td><td>0.04</td></tr><tr><td>&#8195;Heart failure</td><td>8318 (18)</td><td>1321 (37)</td><td>&lt; 0.001</td><td>0.44</td><td>1233 (35)</td><td>1317 (37)</td><td>0.04</td><td>0.05</td></tr><tr><td>&#8195;Atrial fibrillation and flutter</td><td>7183 (16)</td><td>1136 (32)</td><td>&lt; 0.001</td><td>0.39</td><td>1132 (32)</td><td>1133 (32)</td><td>0.98</td><td>0.001</td></tr><tr><td>&#8195;Overweight and obesity</td><td>10,647 (23)</td><td>1319 (17)</td><td>&lt;0.001</td><td>0.31</td><td>1232 (35)</td><td>1315 (37)</td><td>0.04</td><td>0.05</td></tr><tr><td>&#8195;Chronic kidney disease</td><td>8263 (18)</td><td>1383 (39)</td><td>&lt; 0.001</td><td>0.48</td><td>1292 (36)</td><td>1379 (39)</td><td>0.03</td><td>0.05</td></tr><tr><td>&#8195;Chronic lower respiratory diseases</td><td>9998 (22)</td><td>1447 (41)</td><td>&lt;0.001</td><td>0.42</td><td>1366 (38)</td><td>1443 (40)</td><td>0.06</td><td>0.04</td></tr><tr><td>&#8195;Tobacco use</td><td>10,045 (22)</td><td>576 (16)</td><td>&lt; 0.001</td><td>0.14</td><td>510 (14)</td><td>576 (16)</td><td>0.03</td><td>0.05</td></tr><tr><td>&#8195;Ischemic stroke</td><td>14,988 (32)</td><td>1986 (56)</td><td>&lt;0.001</td><td>0.48</td><td>1910 (54)</td><td>1983 (56)</td><td>0.08</td><td>0.04</td></tr><tr><td>&#8195;Nontraumatic intracerebral hemorrhage</td><td>2322 (5)</td><td>248 (7)</td><td>&lt;0.001</td><td>0.08</td><td>235 (7)</td><td>248 (7)</td><td>0.54</td><td>0.02</td></tr><tr><td>&#8195;Nontraumatic subarachnoid hemorrhage</td><td>1179 (3)</td><td>100 (3)</td><td>0.36</td><td>0.02</td><td>92 (3)</td><td>100 (3)</td><td>0.56</td><td>0.01</td></tr><tr><td>&#8195;Acute myocardial infarction</td><td>5740 (12)</td><td>693 (19)</td><td>&lt;0.001</td><td>0.19</td><td>628 (18)</td><td>693 (19)</td><td>0.05</td><td>0.05</td></tr><tr><td>&#8195;Pulmonary embolism</td><td>2239 (5)</td><td>349 (10)</td><td>&lt;0.001</td><td>0.19</td><td>327 (9)</td><td>347 (10)</td><td>0.42</td><td>0.02</td></tr><tr><td>&#8195;Other venous embolism and thrombosis</td><td>6164 (13)</td><td>632 (18)</td><td>&lt;0.001</td><td>0.12</td><td>552 (16)</td><td>629 (18)</td><td>0.01</td><td>0.06</td></tr><tr><td colspan="9"><bold>Medications</bold></td></tr><tr><td>&#8195;Aspirin</td><td>18,889 (41)</td><td>2333 (65)</td><td>&lt;0.001</td><td>0.51</td><td>2279 (64)</td><td>2329 (65)</td><td>0.22</td><td>0.03</td></tr><tr><td>&#8195;Clopidogrel</td><td>7055 (15)</td><td>1024 (29)</td><td>&lt;0.001</td><td>0.33</td><td>993 (28)</td><td>1022 (29)</td><td>0.45</td><td>0.02</td></tr><tr><td>&#8195;Warfarin</td><td>3702 (8)</td><td>631 (18)</td><td>&lt;0.001</td><td>0.29</td><td>596 (17)</td><td>628 (18)</td><td>0.32</td><td>0.02</td></tr><tr><td>&#8195;Apixaban</td><td>3704 (8)</td><td>658 (18)</td><td>&lt;0.001</td><td>0.31</td><td>648 (18)</td><td>655 (18)</td><td>0.83</td><td>0.01</td></tr><tr><td>&#8195;Rivaroxaban</td><td>1469 (3)</td><td>297 (8)</td><td>&lt;0.001</td><td>0.22</td><td>267 (8)</td><td>295 (8)</td><td>0.22</td><td>0.03</td></tr><tr><td>&#8195;Dabigatran</td><td>213 (0.5)</td><td>42 (1)</td><td>&lt;0.001</td><td>0.08</td><td>43 (1)</td><td>42 (1)</td><td>0.91</td><td>0.003</td></tr></tbody></table><table-wrap-foot><p>Values are represented as mean (standard deviation) or <italic>N</italic> (% of column).</p></table-wrap-foot></table-wrap></p>